The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The endogenous cannabinoid system controls extinction of aversive memories
Abstract
Acquisition and storage of aversive memories is one of the basic principles of central nervous systems throughout the animal kingdom. In the absence of reinforcement, the resulting behavioural response will gradually diminish to be finally extinct. Despite the importance of extinction, its cellular mechanisms are largely unknown. The cannabinoid receptor 1 (CB1) and endocannabinoids are present in memory-related brain areas and modulate memory. Here we show that the endogenous cannabinoid system has a central function in extinction of aversive memories. CB1-deficient mice showed strongly impaired short-term and long-term extinction in auditory fear-conditioning tests, with unaffected memory acquisition and consolidation. Treatment of wild-type mice with the CB1 antagonist SR141716A mimicked the phenotype of CB1-deficient mice, revealing that CB1 is required at the moment of memory extinction. Consistently, tone presentation during extinction trials resulted in elevated levels of endocannabinoids in the basolateral amygdala complex, a region known to control extinction of aversive memories. In the basolateral amygdala, endocannabinoids and CB1 were crucially involved in long-term depression of GABA (gamma-aminobutyric acid)-mediated inhibitory currents. We propose that endocannabinoids facilitate extinction of aversive memories through their selective inhibitory effects on local inhibitory networks in the amygdala.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Following their binding to central nervous system receptors (e.g.CB1 receptors), endocannabinoids have been shown, e.g., to reduce anxiety (Marsicano et al., 2002;Lutz et al., 2015) and increase food intake (Di Marzo et al., 2001).”
From Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (2016) · cites this paper as Marsicano et al., 2002
In the citing paper
“Moreover, there is an emerging body of evidence demonstrating an important role for CB1 receptor-mediated endocannabinoid signaling in the extinction of aversive memories8.”
From Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study (2013) · cites this paper as [8]
In the citing paper
“As part of this protective role under aversive conditions, elevated EC signaling during stress has been shown to dampen the development of anxiety [12] and to regulate the encoding [13], retrieval [14] and extinction [15] of traumatic memories.”
From Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder (2013) · cites this paper as [15]
In the citing paper
“Additionally, inhibition of FAAH facilitates long-term fear extinction and rescues deficient fear extinction in rodent models by enhancing AEA–CB1 (cannabinoid type 1) receptor signaling and synaptic plasticity in the BLA.”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“Marsicano and colleagues reported elevated AEA and 2-AG BLA levels after extinction training in mice [86]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“One notable finding is that a CB1R-dependent form of synaptic plasticity in BLA [51,86], long-term depression of inhibitory GABAergic transmission (LTDi), is enhanced by FAAH KO [51] and by the FAAH inhibitor AM3506 at doses that promote extinction [50].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“and produced impairments in extinction learning (but not fear conditioning) by CB1R KO or systemic antagonist (SR141716A) administration [28,86]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“This suggests a scheme in which AEA released during extinction relieves a tonic inhibitory brake on BLA output neurons [50,51,86] necessary for the encoding of extinction memories [102] (Figure 2).”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“The cannabinoid system is part of the complex circuitry that regulates anxiety and stress and is a crucial mediator of emotional learning (Marsicano et al, 2002;Viveros et al, 2005;Patel et al, 2005Patel et al, , 2005a; Laviolette and Grace, 2006;Varvel et al, 2007;Ganon-Elazar and Akirav, 2009;Lutz, 2009;Hill et al, 2009;Abush and Akirav, 2010;Akirav, 2011).”
From Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (2012) · cites this paper as Marsicano et al, 2002
Citations
Cites
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Genetic enhancement of learning and memory in mice
Tang, Y., Shimizu, E., Dubé, G., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999) · Nature · doi:10.1038/43432 · Cited by 1,878
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
The role of ventromedial prefrontal cortex in the recovery of extinguished fear
Quirk, G. J., Russo, G. K., Barron, J. L., & Lebron, K. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06225.2000 · Cited by 957 · cited 1×
“; however, there is increasing evidence that some cellular pathways are specifically involved in extinction, but not in acquisition or consolidation of fear memorie”
BackgroundMarsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937
Self-citationExtinction of emotional learning: contribution of medial prefrontal cortex
Morgan, M. A., Romanski, L. M., & LeDoux, J. E. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90241-c · Cited by 897 · cited 1×
“To confirm this assumption, we measured in C57BL/6J mice levels of the two major endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), in brain punches of the medial prefrontal cortex (mPFC) and the basolateral amygdala complex (BLAC), both of which are thought to have central roles in extinction of av…”
BackgroundOhno‐Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 874
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Flagged first, then by citations
Research works printed but not linked: 1
- Franklin, K. B. J. & Paxinos, G. The Mouse Brain (Academic, San Diego, 1997)
Cited by
Sorted by citations
Items 501–600 of 1,005
Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity
Hansen, H. H., Krutz, B., Sifringer, M., Stefovska, V. G., Bittigau, P., Pragst, F., Marsicano, G., Lutz, B., & Ikonomidou, C. (2007) · Annals of Neurology · doi:10.1002/ana.21287 · Cited by 79
Self-citationTrazzi, S., Steger, M., Mitrugno, V. M., Bartesaghi, R., & Ciani, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.043711 · Cited by 80
Hong, I., Song, B., Lee, S., Kim, J., Kim, J., & Choi, S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07004.x · Cited by 80
Trettel, J., Fortin, D. A., & Levine, E. S. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.058198 · Cited by 79
The Role of Cannabinoid Receptors in the Descending Modulation of Pain
Palazzo, E., Luongo, L., de Novellis, V., Rossi, F., & Maione, S. (2010) · Pharmaceuticals · doi:10.3390/ph3082661 · Cited by 80
Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
Reggio, P. H. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454577 · Cited by 78
Marquart, S., Zerr, P., Akhmetshina, A., Palumbo, K., Reich, N., Tomčík, M., Horn, A., Dees, C., Engel, M., Zwerina, J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27642 · Cited by 85
Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
Hillard, C. J., & Liu, Q.-S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660735 · Cited by 82
Jacob, W., Marsch, R., Marsicano, G., Lutz, B., & Wotjak, C. T. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.04.008 · Cited by 78
Self-citationSupraspinal modulation of pain by cannabinoids: the role of GABA and glutamate
Rea, K., Roche, M., & Finn, D. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707440 · Cited by 81
Blockade of amygdala metabotropic glutamate receptor subtype 1 impairs fear extinction
Kim, J., Lee, S., Park, H., Song, B., Hong, I., Geum, D., Shin, K., & Choi, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.125 · Cited by 78
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia
Fakhoury, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9697-5 · Cited by 81
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder
Betthauser, K. D., Pilz, J., & Vollmer, L. E. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140523 · Cited by 78
Exogenous and Endogenous Cannabinoids Control Synaptic Transmission in Mice Nucleus Accumbens
Robbe, D., Alonso, G., & Manzoni, O. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.013 · Cited by 78
Manna, S. S. S., & Umathe, S. N. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.02.003 · Cited by 77
Hippocampal clock regulates memory retrieval via Dopamine and PKA-induced GluA1 phosphorylation
Hasegawa, S., Fukushima, H., Hosoda, H., Serita, T., Ishikawa, R., Rokukawa, T., Kawahara‐Miki, R., Zhang, Y., Ohta, M., Okada, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13554-y · Cited by 78
Petrosino, S., Moriello, A. S., Verde, R., Allarà, M., Imperatore, R., Ligresti, A., Mahmoud, A. M., Peritore, A. F., Iannotti, F. A., & Marzo, V. D. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1671-5 · Cited by 76
Clinical correlates of stress-induced analgesia: Evidence from pharmacological studies
Ford, G. K., & Finn, D. P. (2008) · Pain · doi:10.1016/j.pain.2008.09.023 · Cited by 77
Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon
Storr, M., Sibaev, A., Marsicano, G., Lutz, B., SCHUSDZIARRA, V., Timmermans, J., & Allescher, H. D. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00148.2003 · Cited by 77
Self-citationNeutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity
Meye, F. J., Trezza, V, Vanderschuren, L. J. M. J., Ramakers, G. M. J., & Adan, R. A. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.145 · Cited by 76
Galiazzo, G., Giancola, F., Stanzani, A., Fracassi, F., Bernardini, C., Forni, M., Pietra, M., & Chiocchetti, R. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1684-7 · Cited by 89
Giusti, A. M., Bignetti, E., & CANNELLA, C. (2007) · Food and Bioprocess Technology · doi:10.1007/s11947-007-0043-9 · Cited by 79
Berardi, A., Schelling, G., & Campolongo, P. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.024 · Cited by 77
Endocannabinoids: Effectors of glucocorticoid signaling
Balsevich, G., Petrie, G. N., & Hill, M. N. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.07.005 · Cited by 82
Human Studies of Cannabinoids and Medicinal Cannabis
Robson, P. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_25 · Cited by 78
Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia
Connell, K., Bolton, N., Olsen, D., Piomelli, D., & Hohmann, A. G. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.008 · Cited by 76
Endocannabinoid Signaling Mediates Psychomotor Activation by Adenosine A 2A Antagonists
Lerner, T. N., Horne, E. A., Stella, N., & Kreitzer, A. C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5844-09.2010 · Cited by 74
Neumeister, A., Seidel, J., Ragen, B., & Pietrzak, R. H. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.012 · Cited by 76
Steenkamp, M. M., Blessing, E., Galatzer‐Levy, I. R., Hollahan, L., & Anderson, W. T. (2017) · Depression and Anxiety · doi:10.1002/da.22596 · Cited by 80
Functional neuroanatomy of the basolateral amygdala: Neurons, neurotransmitters, and circuits
McDonald, A. J. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-815134-1.00001-5 · Cited by 84
Bisogno, T., Mahadevan, A., Coccurello, R., Chang, J. W., Allarà, M., Chen, Y., Giacovazzo, G., Lichtman, A. H., Cravatt, B. F., Moles, A., et al. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12013 · Cited by 74
Self-citationKlinger-Gratz, P. P., Ralvenius, W. T., Neumann, E., Kato, A., Nyilas, R., Lele, Z., Katona, I., & Zeilhofer, H. U. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1945-17.2017 · Cited by 80
Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex
Dı́ez-Alarcia, R., Ibarra‐Lecue, I., López‐Cardona, A. P., Meana, J. J., Gutiérrez‐Adán, A., Callado, L. F., Agirregoitia, E., & Urigüen, L. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00415 · Cited by 73
The role of ventral and dorsal striatum mGluR5 in relapse to cocaine-seeking and extinction learning
Knackstedt, L. A., Trantham‐Davidson, H., & Schwendt, M. (2013) · Addiction Biology · doi:10.1111/adb.12061 · Cited by 75
Transgenic Inhibition of Neuronal Protein Kinase A Activity Facilitates Fear Extinction
Isiegas, C., Park, A., Kandel, E. R., Abel, T. G., & Lattal, K. M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2743-06.2006 · Cited by 75
Liquid crystals in biology I. Historical, biological and medical aspects
Stewart, G. T. (2003) · Liquid Crystals · doi:10.1080/0267829031000097457 · Cited by 72
Withdrawal from THC during adolescence: Sex differences in locomotor activity and anxiety
Harte‐Hargrove, L. C., & Dow-Edwards, D. L. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.02.048 · Cited by 73
Péterfi, Z., Urbán, G. M., Papp, O. I., Németh, B., Monyer, H., Szabó, G., Erdélyi, F., Mackie, K., Freund, T. F., Hájos, N., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1676-12.2012 · Cited by 73
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity
Butti, E., Bacigaluppi, M., Rossi, S., Cambiaghi, M., Bari, M., Cebrián‐Silla, A., Brambilla, E., Musella, A., Ceglia, R. D., Teneud, L., et al. (2012) · Brain · doi:10.1093/brain/aws194 · Cited by 75
Synaptic activation of kainate receptors gates presynaptic CB1 signaling at GABAergic synapses
Lourenço, J., Cannich, A., Carta, M., Coussen, F., Mulle, C., & Marsicano, G. (2010) · Nature Neuroscience · doi:10.1038/nn.2481 · Cited by 69
Self-citationTesting the effects of Δ9-THC and D-cycloserine on extinction of conditioned fear in humans
Klumpers, F., Denys, D., Kenemans, J. L., Grillon, C., van der Aart, J., & Baas, J. M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111431624 · Cited by 72
Galdino, G., Romero, T., Pinho da Silva, J. F., Aguiar, D., de Paula, A. M., Cruz, J., Parrella, C., Piscitelli, F., Duarte, I., Di Marzo, V., et al. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000340 · Cited by 72
Cassano, T., Gaetani, S., Macheda, T., Laconca, L., Romano, A., Morgese, M. G., Cimmino, C. S., Chiarotti, F., Bambico, F. R., Gobbi, G., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2051-0 · Cited by 72
Sex‐dependent effects of endocannabinoid modulation of conditioned fear extinction in rats
Morena, M., Nastase, A. S., Santori, A., Cravatt, B. F., Shansky, R. M., & Hill, M. N. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15341 · Cited by 72
Endocannabinoid modulation of fear responses: learning and state-dependent performance effects
Reich, C. G., Mohammadi, M., & Alger, B. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107083999 · Cited by 72
Distribution and function of monoacylglycerol lipase in the gastrointestinal tract
Duncan, M., Thomas, A. D., Cluny, N. L., Patel, A., Patel, K. D., Lutz, B., Piomelli, D., Alexander, S. P. H., & Sharkey, K. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90500.2008 · Cited by 71
Self-citationCannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders
Carvalho, A. F., & Bockstaele, E. J. V. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.01.008 · Cited by 72
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression
Mangieri, R. A., & Piomelli, D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.003 · Cited by 73
Bartelt, A., Orlando, P., Mele, C., Ligresti, A., Toedter, K., Scheja, L., Heeren, J., & Marzo, V. D. (2011) · Diabetologia · doi:10.1007/s00125-011-2274-6 · Cited by 71
Understanding Neuropathic Pain
Zieglgänsberger, W., Berthele, A., & Tölle, T. R. (2005) · CNS Spectrums · doi:10.1017/s1092852900022628 · Cited by 69
Self-citationCB1 cannabinoid receptor-mediated aggressive behavior
Rodríguez‐Arias, M., Navarrete, F., Daza‐Losada, M., Navarro, D., Aguilar, M. A., Berbel, P. J., Miñarro, J., & Manzanares, J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.013 · Cited by 72
Mechanisms of Musculoskeletal Physiotherapy
Zusman, M. (2004) · Physical Therapy Reviews · doi:10.1179/108331904225003973 · Cited by 73
Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future
Koek, R. J., Schwartz, H. N., Scully, S., Langevin, J., Spangler, S. L., Korotinsky, A., Jou, K., & Leuchter, A. F. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.01.015 · Cited by 74
Huang, Y.-C., Wang, S., Chiou, L., & Gean, P. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10311.2003 · Cited by 70
Raut, S. B., Marathe, P. A., van Eijk, L., Eri, R. D., Ravindran, M., Benedek, D. M., Ursano, R. J., Canales, J. J., & Johnson, L. R. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108195 · Cited by 74
Zhu, P., & Lovinger, D. M. (2007) · Journal of Neurophysiology · doi:10.1152/jn.01228.2006 · Cited by 69
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1
Heitland, I., Klumpers, F., Oosting, R. S., Evers, D. J. J., Kenemans, J. L., & Baas, J. M. P. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.90 · Cited by 72
Terzian, A. L. B., Micale, V., & Wotjak, C. T. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12561 · Cited by 69
Self-citationModulation of Fear and Anxiety by the Endogenous Cannabinoid System
Chhatwal, J. P., & Ressler, K. J. (2007) · CNS Spectrums · doi:10.1017/s1092852900020939 · Cited by 71
Azad, S. C., Kurz, J., Marsicano, G., Lutz, B., Zieglgänsberger, W., & Rammes, G. (2008) · Learning & Memory · doi:10.1101/lm.741908 · Cited by 68
Self-citationEndocannabinoids and Mental Disorders
Rubino, T., Zamberletti, E., & Parolaro, D. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_9 · Cited by 72
Butler, R. K., Rea, K., Lang, Y., Gavin, A. M., & Finn, D. P. (2008) · Pain · doi:10.1016/j.pain.2008.10.002 · Cited by 69
Cognitive enhancers for anxiety disorders
Hofmann, S. G., Smits, J. A. J., Asnaani, A., Gutner, C. A., & Otto, M. W. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.11.020 · Cited by 69
Marco, E. M., Granstrem, O., Moreno, E., Llorente, R., Adriani, W., Giovanni Laviola, A., & Viveros, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.013 · Cited by 67
Ward, S. J., Rosenberg, M., Dykstra, L., & Walker, E. A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.07.002 · Cited by 68
Guagnini, F., Valenti, M., Mukenge, S., Matias, I., Bianchetti, A., Palo, S. D., Ferla, G., Marzo, V. D., & Croci, T. (2006) · Gut · doi:10.1136/gut.2005.076372 · Cited by 68
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson’s disease
Celorrio, M., Fernández‐Suárez, D., Rojo-Bustamante, E., Echeverry‐Alzate, V., Ramírez, M. J., Hillard, C. J., López‐Moreno, J. A., Maldonado, R. J., Oyarzábal, J., Franco, R., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.06.010 · Cited by 68
Moreno, E., Chiarlone, A., Medrano, M., Puigdellívol, M., Bibič, L., Howell, L. A., Resel, E., Puente, N., Casarejos, M. J., Perucho, J., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.12 · Cited by 66
Self-citationChronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD
Fidelman, S., Zer‐Aviv, T. M., Lange, R., Hillard, C. J., & Akirav, I. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.02.004 · Cited by 69
Bukalo, O., Pinard, C. R., & Holmes, A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12779 · Cited by 73
Kuhnert, S., Meyer, C., & Koch, M. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.05.002 · Cited by 67
Tjen‐A‐Looi, S. C., Li, P., & Longhurst, J. C. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00142.2009 · Cited by 67
Developmental regulation of fear learning and anxiety behavior by endocannabinoids
Lee, T. T.-Y., Hill, M. N., & Lee, F. S. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12253 · Cited by 71
PARKER, L., KWIATKOWSKA, M., & Mechoulam, R. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.08.045 · Cited by 67
Laere, K. V., Goffin, K. E., Bormans, G. M., Casteels, C., Mortelmans, L., Hoon, J. N. J. M. D., Grachev, I. D., Vandenbulcke, M., & Pieters, G. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.530 · Cited by 67
Lange, M. D., Daldrup, T., Remmers, F., Szkudlarek, H. J., Lesting, J., Guggenhuber, S., Ruehle, S., Jüngling, K., Seidenbecher, T., Lutz, B., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.156 · Cited by 66
Self-citationBlockade of cannabinoid CB1 receptors alters contextual learning and memory.
Arenos, J. D., Musty, R., & Bucci, D. J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.04.017 · Cited by 74
D’Argenio, G., Petrosino, S., Gianfrani, C., Valenti, M., Scaglione, G., Grandone, I., Nigam, S., Sorrentini, I., Mazzarella, G., & Marzo, V. D. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0192-3 · Cited by 67
Xia, Z., & Storm, D. R. (2012) · Learning & Memory · doi:10.1101/lm.027128.112 · Cited by 70
Finn, D. P., Beckett, S. R. G., Richardson, D., Kendall, D. A., Marsden, C. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03509.x · Cited by 66
deRoon‐Cassini, T. A., Bergner, C., Chesney, S. A., Schumann, N. R., Lee, T. S., Brasel, K. J., & Hillard, C. J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01808-1 · Cited by 65
Local modulation by presynaptic receptors controls neuronal communication and behaviour
Lovinger, D. M., Mateo, Y., Johnson, K. A., Engi, S. A., Antonazzo, M., & Cheer, J. F. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00561-0 · Cited by 69
Engeli, S. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-24716-3_17 · Cited by 66
Ney, L. J., Matthews, A. J., Bruno, R., & Felmingham, K. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.006 · Cited by 70
Siracusa, R., Impellizzeri, D., Cordaro, M., Crupi, R., Esposito, E., Petrosino, S., & Cuzzocrea, S. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00233 · Cited by 65
Chronic Pain and Psychiatric Conditions
Johnston, K. J. A., & Huckins, L. M. (2022) · Complex Psychiatry · doi:10.1159/000527041 · Cited by 81
Marco, E. M., & Laviola, G. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408459 · Cited by 67
Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus
Yasuda, H., Huang, Y. Y., & Tsumoto, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708349105 · Cited by 68
Bilkei‐Gorzó, A., Drews, E., Albayram, Ö., Piyanova, A., Gaffal, E., Tueting, T., Michel, K., Mauer, D., Maier, W., & Zimmer, A. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.009 · Cited by 64
Wiskerke, J., Irimia, C., Cravatt, B. F., Vries, T. J. D., Schoffelmeer, A. N. M., Pattij, T., & Parsons, L. H. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300036b · Cited by 68
Projection-Specific Dynamic Regulation of Inhibition in Amygdala Micro-Circuits
Vogel, E., Krabbe, S., Gründemann, J., Cusulin, J. I. W., & Lüthi, A. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.036 · Cited by 70
Microglial production of TNF-alpha is a key element of sustained fear memory
Yu, Z., Fukushima, H., Ono, C., Sakai, M., Kasahara, Y., Kikuchi, Y., Gunawansa, N., Takahashi, Y., Matsuoka, H., Kida, S., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.08.011 · Cited by 65
Zimmermann, T., Bartsch, J., Beer, A., Lomazzo, E., Guggenhuber, S., Lange, M. D., Bîndilă, L., Pape, H., & Lutz, B. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0274-7 · Cited by 68
Self-citationAnimal models of post-traumatic stress disorder and novel treatment targets
Aspesi, D., & Pinna, G. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000467 · Cited by 67
Yasmin, F., Colangeli, R., Morena, M., Filipski, S. B., van der Stelt, M., Pittman, Q. J., Hillard, C. J., Teskey, G. C., McEwen, B. S., Hill, M. N., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910322116 · Cited by 65
Haney, M., & Evins, A. E. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.251 · Cited by 67
Pan, B., Zhong, P., Sun, D., & Liu, Q.-S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1040-11.2011 · Cited by 64
Cannabinoids and glucocorticoids modulate emotional memory after stress
Akirav, I. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.08.002 · Cited by 65
The effects of alcoholism on the human basolateral amygdala
Kryger, R., & Wilce, P. A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.061 · Cited by 64
Diffusion dynamics of synaptic molecules during inhibitory postsynaptic plasticity
Petrini, E. M., & Barberis, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00300 · Cited by 65
Metadata
- Authors
- Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., Di Marzo, V., & Lutz, B.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- LMU Klinikum (DE)
- Istituto di Chimica Biomolecolare (IT)
- Helmholtz Munich (DE)
- Corresponding author
- Lutz, Beat
- Venue
- Nature
- Published
- 2002-08
- Volume
- 418
- Issue
- 6897
- Pages
- 530-534
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1982291289
- Cited by
- 1,728
- References
- 30
- Citations by year
- 2026: 22 · 2025: 39 · 2024: 41 · 2023: 48 · 2022: 60 · 2021: 61 · 2020: 60 · 2019: 70 · 2018: 64 · 2017: 77 · 2016: 75 · 2015: 87 · 2014: 90 · 2013: 87 · 2012: 85
- FWCI
- 42.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- endocannabinoid system, CB1 receptor, CB1 knockout mice, fear extinction, auditory fear conditioning, basolateral amygdala, long-term depression, GABAergic inhibition, SR141716A, memory consolidation, inhibitory neural networks
- MeSH terms
- Rimonabant, Acoustic Stimulation, Amygdala, Animals, Cannabinoids, Conditioning, Classical, Electrophysiology, Extinction, Psychological, Fear, gamma-Aminobutyric Acid, Male, Memory, Mice, Inbred C57BL, Neuronal Plasticity, Neurons, Piperidines, Pyrazoles, Receptors, Drug, Synapses, Gene Deletion, Mice, Knockout, Receptors, Cannabinoid, Mice, Cannabinoid Receptor Modulators, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
